Global /China /Healthcare /Drug Manufacturers - General /002907

Chongqing Pharscin Pharmaceutical Co., Ltd.

002907

• SHE: 002907 • Delayed

13.95CNY 0.1%

2.06 USD

As of 15 June 2026, Chongqing Pharscin Pharmaceutical Co., Ltd. has a market cap of $858.49M USD, ranking #11635 globally and #3381 in China. It ranks #1057 in the Healthcare sector, and #397 in the Drug Manufacturers - General industry.

Global Rank

11635

Country Rank

3381

Sector Rank

1057

Industry Rank

397

Key Stats

Market Cap

$858.49MUSD

5.82B CNY

Enterprise Value

$770.04MUSD

5.21B CNY

Revenue (TTM)

$122.07MUSD

827.14M CNY

EBITDA (TTM)

$20.47MUSD

138.5M CNY

Net Income (TTM)

$9.61MUSD

65.09M CNY

EBITDA Margin

17%

Profit Margin

7.9%

PE Ratio

89.4

PS Ratio

7.0

PB Ratio

3.4

EV/EBITDA

37.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Xiaoying Liu open_in_new

Employees

1,384

Founded

1996

Website

pharscin.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	1.3%	2.3%	-5.8%	-14%	-5.1%	0.8%	-14%	17%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002907 重庆华森制药股份有限公司 Class A ISIN: CNE100003308 Shares Out.: Shares Outstanding: 417.596M¹ Shares Float: 128.412M² TV: TradingView: SZSE: 002907 SA: Stock Analysis: SHE: 002907 YF: Yahoo Finance: 002907.SZ GF: Google Finance: SHE: 002907 BA: Barron's: 002907 MS: Morningstar: XSHE: 002907	13.95 CNY	TV: TradingView: SZSE: 002907 SA: Stock Analysis: SHE: 002907 YF: Yahoo Finance: 002907.SZ GF: Google Finance: SHE: 002907 BA: Barron's: 002907 MS: Morningstar: XSHE: 002907

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Chongqing Pharscin Pharmaceutical Co., Ltd.

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 89K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 64K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 42K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 37K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 34K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 32K%	20.5	Switzerland

chevron_leftBack